Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discussed a new week for stocks as Wall Street remains on stimulus watch, with Speaker Pelosi setting a 48-hour deadline for reaching an aid deal with the White House.   More

Carl Quintanilla, David Faber and Leslie Picker discussed today’s stock rally, looking to snap a 3-day losing streak as September retail sales surprise to the upside. Plus shares of Pfizer rally, the drug maker saying it sees an emergency use filing for its COVID-19 vaccine only after the U.S.   More

Carl Quintanilla, Jim Cramer and David Faber discussed a rough morning for stocks As worries about an impasse in the stimulus talks and worries about a coronavirus “2nd Wave” spark a sell-off on Wall Street.   More

Carl Quintanilla, Jim Cramer and David Faber discussed another big day of bank earnings, with Bank of America, Goldman Sachs and Wells posting results before the beginning of trading — as stocks look to rebound after snapping a four-day win streak.   More

As stocks entered the morning with a four-day win streak, Carl Quintanilla, Jim Cramer and David Faber discussed what’s ahead for the markets with earnings season getting underway. The anchors took an in-depth look at better-than-expected results from JPMorgan Chase and Citigroup as well as the challenges facing both banks.   More

Carl Quintanilla, Jim Cramer and David Faber discussed the upward momentum for stocks as we begin a new trading week. The anchors previewed what to expect from this week’s bank earnings, with the first results due out Tuesday.   More

Carl Quintanilla, Jim Cramer and David Faber discussed the big corporate story of the day: Chipmaker AMD reportedly in advance talks to buy Xilinx in a deal that could be worth more than $30-billion.   More

Carl Quintanilla, Jim Cramer and David Faber discussed an upbeat morning for stocks, rising on hopes Congress will approve a stimulus package — with President Trump saying that aid talks are beginning to work out.   More

Carl Quintanilla, Jim Cramer and David Faber discussed the big rebound in stocks after President Trump tweeted that he would approve a series of coronavirus relief measures — a change from Tuesday when stocks fell sharply after the president tweeted the White House would halt stimulus talks with Democrats.   More

With the Dow coming off its best day since July, Carl Quintanilla, Jim Cramer and David Faber discussed the road ahead for stocks as Wall Street pays close attention to COVID-19, President Trump’s health, and the push for treatments and vaccines.   More

Carl Quintanilla, Jim Cramer and David Faber focused on stocks’ positive start to a new week of trading, Wall Street hoping that President Trump is recovering from COVID-19 and that the stimulus talks will result in Congress passing a relief bill.   More

Carl Quintanilla, Jim Cramer and David Faber focused on the big story of the day: President Trump testing positive for COVID-19 and the market’s negative reaction to that news. They discussed its impact on the road ahead for stocks, the stimulus talks, reopening plans across the nation, the presidential election and the Supreme Court nomination schedule.   More

Carl Quintanilla, Jim Cramer and David Faber discussed what’s ahead for the stock markets in the 4th quarter after coming off their best quarter since 2017. This as Wall Street pays close attention to the stimulus talks in Washington, with airlines announcing furloughs since Congress has yet to strike a deal on a COVID-relief package.   More

Carl Quintanilla, Jim Cramer and David Faber discussed market reaction to Tuesday night’s presidential debate and what’s at stake for stocks. That was followed by CNBC and Institutional Investor’s “Delivering Alpha” conference: Becky Quick conducted a live interview with Treasury Secretary Steven Mnuchin about the economy and the COVID-19 stimulus talks.   More

Carl Quintanilla, Jim Cramer and David Faber discussed in-depth the COVID-19 stimulus talks and the Democrats’ new $2.2-trillion coronavirus aid package and how the impasse in the talks has taken a toll on businesses such as restaurants and the push to revive the economy.   More

Carl Quintanilla, Kelly Evans & Mike Santoli discuss the Monday rally for stocks, building on Friday’s sharp gains as the Dow and S&P look to snap their first 4-week losing streak of 2020.    More

Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year.    More

Jim Cramer and David Faber discuss the September slump for stocks, volatility continuing as wall street seeks to recover from the worst sell-off in 2 weeks. Goldman Sachs cuts its Q4 GDP outlook amid diminished hopes for a DC stimulus deal.   More

Carl Quintanilla, Jim Cramer and David Faber discussed news out of Johnson & Johnson. The company’s COVID-19 vaccine candidate has entered late-stage testing. They also weighed in on the rally in Nike shares after the company’s quarterly results blew past street expectations.   More

Carl Quintanilla, Jim Cramer and David Faber discussed what’s next for the markets after Monday’s sell-off, especially when ot comes to high-profile stocks that have recently taken a hit. They also previewed what to expect from Tesla’s “Battery Day” which gets underway after the close of trading today.   More